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The role of translation elongation factor eEF1A in
intracellular alkalinization-induced tumor cell growth
Juno Kim1, Wan Namkung1, Jae Seok Yoon, Min Jae Jo, Sung Hee Lee, Kyung Hwan Kim, Joo Young Kim
and Min Goo Lee
The formation of a pH gradient, which is characterized by intracellular alkalinization and extracellular acidification, plays a
key role in the growth and metastasis of tumor cells. However, the underlying mechanisms of alkalinization-induced cell
growth are not known. In this study, we investigated the roles of eukaryotic translation elongation factor 1 a (eEF1A) in
alkalinization-induced cell growth. In all cell lines tested (NIH3T3, HEK293, and HeLa), cell growth was affected by the
modulation of intracellular pH. In general, weak intracellular alkalinization produced increased cell growth, whereas
intracellular acidification resulted in decreased cell growth. It is interesting to note that portions of actin-bound eEF1A
proteins were gradually reduced from acidic to alkaline conditions, suggesting an increase in levels of functionally active,
free-form eEF1A. Over-expression of eEF1A caused increased cell growth in HeLa cells. It should be noted that dis-
sociation of eEF1A from actin by transfection with the actin-binding domain deleted eEF1A construct further increased
cell growth under acidic conditions, whereas most of the intact eEF1A was bound to actin. Conversely, knockdown of
eEF1A by treatment with eEF1A1 and eEF1A2 siRNAs nullified the effects of alkalinization-induced cell growth. The above
findings suggest that an increase in free-form eEF1A under alkaline conditions plays a critical role in alkalinization-induced
cell growth.
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Tumor cells that harbor a significant growth advantage have
several different hallmarks including a high degree of in-
tracellular alkalinization and an abnormal glycolytic meta-
bolism.1 Cellular alkalinization is one of the most common
phenotypes of tumor cells and it is because of their ability to
secrete protons, and acidify their extracellular environment.
Alkaline intracellular pH (pHi) and acidic extracellular pH
(pHe) create a reversed pH gradient across the cell mem-
brane, which is the earliest step of neoplastic progression.1,2
Tumor cells activate membrane-based ion exchangers, such as
the Naþ /Hþ exchanger 1 (NHE1), the Cl-/HCO3
- exchanger,
Hþ -ATPase proton pump, and the Hþ /lactate co-transpor-
ter to maintain the reverse pH gradient.3–5
NHE1, the housekeeping isoform of the Naþ /Hþ
exchanger, is ubiquitously distributed in most tissues and has
an important role in the regulation of pHi by exchanging
intracellular protons [Hþ ]i for extracellular sodium
[Naþ ]e.
6–8 The transformed cells and tumor cells differ from
normal tissues in that they have constitutive NHE1 activity at
resting pHi, resulting in an increased pHi.
1,9 Intracellular
alkalinization induced by the activation of NHE1 in tumor
cells has been shown to play key role in the maintenance and
progression of the neoplastic state. For example, transfor-
mation of human keratinocytes by the E7 oncogene of hu-
man papillomavirus type 16 showed NHE1 activation as a
key mechanism in malignant transformation.10 This activa-
tion of NHE1, with consequent cytoplasmic alkalinization,
appears to be involved in the universal regulation of tumor
progression when quiescent cells commit to proliferate.10,11
However, the underlying molecular mechanisms of alkalini-
zation-induced cell growth are still poorly understood.
One of the key proteins in cell proliferation and growth is
eukaryotic elongation factor 1 a (eEF1A). During protein
translation, eEF1A recruits aminoacyl t-RNA to the ribosome
and translocates the growing polypeptide from the ribosomal
A site to the P site.12 eEF1A is one of the most abundant
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proteins in the cell, comprising 1–2% of total proteins, and is
highly conserved.13–15 There are two human isoforms of
eEF1A, eEF1A1 and eEF1A2, which share more than 90%
homology by amino-acid sequencing. eEF1A1 is expressed
ubiquitously, whereas eEF1A2 expression is restricted to the
heart, the brain, and the skeletal muscles in humans and
rodents.16,17 It has been shown that increased expression of
eEF1A1 and eEF1A2 proteins is associated with increased cell
proliferation, oncogenic transformation, and delayed cell
senescence.14,18,19
It is interesting to note that cellular redistribution of
eEF1A is related to pHi.
14,19 The eEF1A proteins in many
species bind to actin filaments and microtubules both in vivo
and in vitro.20 The binding affinity of eEF1A for F-actin
diminishes with increasing pHi, and eEF1A dissociates from
F-actin in alkaline conditions. In Dictyostelium, the total
amount of free-form eEF1A increases by 60% upon
intracellular alkalinization from pH 6.0 to 8.0.19 In general, it
is believed that eEF1A and other translational cofactors are
complexed with F-actin in specific regions of the cell, and a
pH-sensitive transition in cytoskeletal association increases
translational efficiency.19 Therefore, it is possible that the
actin-binding properties of eEF1A and its cellular distri-
bution are the primary targets in alkalinization-dependent
tumor cell growth.
The present study was undertaken to investigate the role of
eEF1A proteins in intracellular alkalinization-induced cell
growth using an integrated molecular functional approach.
The results in this study indicate that an increase in the
amount of unbound free-form eEF1A under alkaline condi-





cein acetoxymethylester (BCECF-AM) was purchased from
Molecular Probes (Eugene, OR, USA). Anti-eEF1A and
anti-Myc monoclonal antibodies were obtained from Upstate
(Lake Placid, NY, USA) and Santa Cruz Biotechnology (Santa
Cruz, CA, USA), respectively. Actin-biotin and immobilized
streptavidin were purchased from Cytoskeleton (Denver, CO,
USA) and PIERCE (Rockford, IL, USA), respectively. Car-
iporide, the NHE1 inhibitor, was synthesized at the Korea
Research Institute of Chemical Technology (Daejon, Kor-
ea).21 All other chemicals including 3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide (MTT), and sodium
dodecyl sulfate (SDS) were purchased from Sigma (St. Louis,
MO, USA). Original constructs of human eEF1A1 (pCMV-
SPORT6) and eEF1A2 (pCNS) were purchased from the
Korea Research Institutive of Bioscience and Biotechnology
(Daejon, Korea). pCMV-eEF1A1, pCMV-eEF1A2, pCMV-
eEF1A1D408–462, and pCMV-eEF1A2D408–463 with
carboxy-terminal Myc tag were PCR-amplified and sub-
cloned into the pcDNA 3.1/Zeo(þ ) vector using the EcoRI
and XbaI sites.
Cell Cultures and Cell Viability Assay
NIH3T3, HEK293, and HeLa cells were maintained in
Dulbecco’s modified Eagle’s medium-high glucose medium
(DMEM-HG; Invitrogen, Carlsbad, CA, USA), supple-
mented with 10% heat-inactivated fetal bovine serum (FBS;
Life Technologies, Gaithersburg, MD, USA), penicillin
(50 IU/ml), and streptomycin (50 mg/ml) at 371C in 10% CO2
incubator. Cells grown in alkaline or acidic conditions were
incubated in 2 and 20% CO2 incubators, respectively. In
addition, a batch of cells were cultured in another acidic
medium, where the standard 44 mM NaHCO3 of DMEM
was replaced with 10 mM NaHCO3 and 34 mM NaCl, and
incubated at 10% CO2 to minimize the possible adverse
effects from high CO2 concentrations. Cells were seeded onto
12-well plates at a density of 1.2 105 cells/mm2. Following
initial 12-h incubation in the standard DMEM at 10% CO2,
the medium was replaced with DMEM-HG pre-incubated at
2, 10, or 20% CO2, or with HCO3
-modified DMEM-HG
pre-incubated at 10% CO2, and the cells were continuously
kept on incubation chambers bearing corresponding CO2
concentrations. In one set of experiments, the NHE1 in-
hibitor cariporide (100 mM) was added to the medium. All
medias were changed every 12 h until the end of the ex-
periment.
The cell proliferation of each sample was determined by
MTT assay. MTT stock solution (5 mg/ml in phosphate-
buffered saline) was added to samples, giving a final MTT
concentration of 1 mg/ml. After the incubation, cells were
treated overnight with 1 volume of lysis buffer (20% SDS in
50% N, N-dimethyl formamide with water, pH 4.7). The
spectrophotometric absorbance of each sample was measured
at 570 nm using a Spectra Microplate Reader (Molecular
Devices, Sunnyvale, CA, USA).
Intracellular pH Measurements
Intracellular pH (pHi) was measured as previously de-
scribed.22 Briefly, cells were cultured on coverslips with the
standard DMEM-HG at 2, 10, or 20% CO2, or with the
HCO3
-modified DMEM-HG at 10% CO2 for 1 day. The cells
were then washed with pre-incubated HCO3
-buffered solu-
tion at each CO2 concentration and assembled to form the
bottom of a perfusion chamber. The HCO3
-buffered solu-
tion contained 110 (or 144) NaCl, 5 KCl, 1 MgCl2, 1 CaCl2,
10 D-glucose, and 44 (or 10) NaHCO3. (in mM/L). The cells
were loaded with the fluorescent pH probe BCECF by in-
cubating for 10 min in each solution containing 2.5 mM
BCECF-AM. After dye loading, cells were perfused with the
appropriate solutions, and the pHi was measured by photon
counting using a fluorescence measuring system (Delta Ram;
PTI Inc., South; Brunswick, NJ, USA). The fluorescence
ratios of 490/440 nm were calibrated intracellularly by
perfusing the cells with solutions containing 145 mM KCl,
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10 mM HEPES, and 5 ı´M nigericin, with the pH adjusted
to 6.2–7.8.
RNA Preparation and RT-PCR
The expression of eEF1As in NIH3T3, HEK293, and HeLa
cells was examined by reverse transcription (RT)-PCR. Total
RNA was prepared from NIH3T3, HEK293, and HeLa cells
using Trizol solution (Invitrogen, Carlsbad, CA, USA) and
reverse-transcribed using random hexa-primers and an
RNase H reverse transcriptase (Invitrogen). The cDNA was
amplified using specific primers and a Taq polymerase
(Promega, Madison, WI, USA), and the products were
separated on 1% agarose gel containing 0.1 mg/ml ethidium
bromide. The primer sequences used are shown in
Supplementary 1.
Actin Binding Assay and Immunoblotting
The pCMV-eEF1A1, pCMV-eEF1A2, pCMV-eEF1A1D408–462,
and pCMV-eEF1A2D408-463 with Myc epitope constructs
were transiently transfected into HeLa cells in a 100-mm
dish using the Lipofectamin Plus Reagent (Invitrogen,
Carlsbad, CA, USA). After 48 h of incubation, cells were lysed
with one of three kinds of pH-modulated actin binding
buffers (20 mM PIPES pH 6.0, 20 mM Tris-HCl pH 7.0, or
20 mM Tris-HCl pH 8.0 solution containing 50 mM KCl,
2 mM MgCl2, 1 mM ATP, 1% Triton X-100, 0.2 mM DTT,
2 mM EGTA, and complete proteinase inhibitor cocktails).
Protein samples (1.5 mg) from cells expressing each construct
were resuspended in the appropriate actin binding buffers
and incubated with 10 mg of actin-biotin at 41C for 18 h.
Then, immobilized streptavidin was added to each sample
and incubated at 41C for 2 h, followed by washing 5 times
with the actin-binding buffer. The biotin-binding proteins or
lysates (30 mg of proteins) were analyzed by immunoblotting.
Briefly, the samples were suspended in SDS sample buffer and
separated by SDS-polyacrylamide gel electrophoresis. The
separated proteins were transferred onto a nitrocellulose
membrane and probed with anti-eEF1A, anti-b actin, or
anti-c-Myc monoclonal antibodies. After being treated with
the appropriate secondary antibodies, protein bands were
visualized using an enhanced chemiluminescence kit
(Amersham Pharmacia), and staining intensities were
analyzed using imaging software (Multi Gauge V3.0, Fuji
Film, Tokyo, Japan).
Over-Expression and Knockdown of eEF1A1 and eEF1A2
The full-length and the carboxy-terminal-deleted (DC)
pCMV-eEF1A constructs were transiently transfected into
HeLa cells in 60-mm dishes using Lipofectamin Plus Reagent
(Invitrogen). After 12-h incubation under the standard
DMEM culture condition, cells were trypsinized and seeded
onto 6- and 12-well plates, and used for immunoblotting and
MTT assay, respectively. The siRNAs targeted to eEF1A1 and
eEF1A2 were purchased from Dharmacon (Lafayette, CO,
USA). siRNA-mediated knockdowns of eEF1A1 and eEF1A2
were carried out according to manufacturer’s instructions.
Briefly, eEF1A1 and eEF1A2 siRNAs (25 pmol) were tran-
siently transfected into HeLa cells in 6- and 12-well plates
using Lipofectamin 2000 (Invitrogen). Samples from the
6-well plates were used for immunoblotting and those from
the 12-well plates were used for analyzing cell growth using
the MTT viability assay.
Statistical Analysis
Results are presented as the mean±s.e.m. for the indicated
number of experiments. The results of multiple experiments
were analyzed using non-paired Student’s t test or analysis of
variance, as appropriate.
RESULTS
Effects of pHi Modulation on Cell Viability
To evaluate the effects of intracellular pH on cell viability,
HeLa, HEK293, and NIH3T3 cells were incubated in different
CO2 concentrations with the standard 44 mM HCO3
-
containing DMEM for 24 h, and altered viability because of
cytoplasmic pH change was determined by MTT assay.
Measurements of pHi in HeLa cells showed that incubation in
2% CO2 increased pHi to 7.57 from the control pHi value of
7.19 at 10% CO2. On the other hand, incubation in the 20%
CO2 incubator decreased pHi to 6.56 (Table 1). Under the
Table 1 Medium pH (pHM) and intracellular pH (pHi) in HeLa cells with the absence or presence of cells and cariporide
Medium HH pHM (without cell) pHM (supernatant)
a pHi pHi (cariporide)
b
2% CO2/44mM HCO3
 8.08 7.68±0.02 7.54±0.04 7.57±0.06 7.54±0.05
10% CO2/44mM HCO3
 7.38 7.35±0.03 7.26±0.07 7.19±0.05 6.62±0.01
20% CO2/44mM HCO3
 7.08 7.06±0.03 7.09±0.05 6.56±0.16 6.23±0.02
10% CO2/10mM HCO3
 6.74 6.71±0.04 6.77±0.02 6.71±0.16 6.54±0.12
Abbreviation: HH, estimation from the Henderson-Hasselbach equation; pHi, intracellular pH and pHM, medium pH.
Values are expressed as means±s.e.m. (n¼ 3).
a
Cell supernatant was collected after a 12-h incubation of cells.
b
The NHE1 inhibitor, cariporide (100 mM), was added during the 12-h incubation and the pHi-measuring period.
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alkaline 2% CO2 condition, HeLa and HEK293 cells showed
significantly higher viability than those under the control
10% CO2 condition. In contrast, all the three cell types
showed low viability under the acidic 20% CO2 condition
(Figure 1a). It is interesting to note that RT-PCR for eEF1A
isoforms in these cells showed that HeLa and HEK293 cells
express both eEF1A1 and eEF1A2, whereas NIH3T3 cells only
had the eEF1A1 isoform (Figure 1b). Considering these re-
sults, HeLa cells were chosen to investigate the role of eEF1A
in intracellular pHi-dependent cell viability because HeLa
cells (1) showed robust pHi-dependent cell viability, (2) had
both isoforms of eEF1A, and (3) originated from a human
cervical adenocarcinoma.
The pHi-dependent viability of HeLa cells was further
explored over variable time periods and with different in-
tracellular acidifying protocols. As shown in Figure 2a, HeLa
cells in the alkaline media showed higher viability than those
in the neutral media by an average of 43% during the 3-day
observation period. Microscopic observations from longer
periods showed that this phenomenon lasted until 80% of
cell confluence had been reached. The low viability in acidic
media was also reproduced while observing 3-day incuba-
tions. It is interesting to note that cells in another acidic
medium, with reduced HCO3
 rather than increased CO2,
also showed low viability (Figure 2a). This result implies that
a decrease in pHi, rather than a high CO2 concentration, is
responsible for the low viability.
NHE1 catalyzes the exchange of Naþ and Hþ across
the cell and is the predominant pH regulator in tumor
cells.1,4 As shown in Table 1, treatment with the NHE1
inhibitor, cariporide, greatly decreases pHi under the stan-
dard 10% CO2 DMEM culture condition. Even in the 20%
CO2 acidic media, NHE1 inhibition further decreases
pHi. However, cariporide did not significantly affect the pHi
in the alkaline medium (Table 1). As the addition of car-
iporide reduced pHi, we addressed whether NHE1 inhibition
could directly inhibit the proliferation of HeLa tumor cells
next. As expected from our pHi measurements, cariporide
greatly decreased cell viability in neutral or acidic mediums
(Figure 2b). These results confirmed that pHi, which
is regulated by NHE1, plays an important role in tumor
cell growth.
Figure 1 pH-dependent cell growth and eukaryotic translation elongation
factor 1 a (eEF1A) expression. (a) Cell viability of NIH3T3, HEK293, and HeLa
cells in the pH-modified media was measured using MTT assay. The 12-well
plates were loaded with 1.2 105 cells/mm2 and left for 12 h in Dulbecco’s
modified Eagle’s medium (DMEM) Then, the medium was replaced with
DMEM pre-incubated at 2, 10, and 20% CO2, and cells were incubated in the
corresponding CO2 incubation chamber for 24 h. Data shown are
mean±s.e.m. (n¼ 9). (b) Expression of eEF1A isoforms was examined by
reverse transcription (RT)-PCR using human (HeLa and HEK293) and mouse
(NIH3T3, mouse brain) eEF1A isoform-specific primers. The primer efficiency
of mouse eEF1A2 was verified using RNA samples from mouse brains. RT-
PCR on b-actin was used as control. *Po0.05, **Po0.01: difference from
neutral.
Figure 2 Effects of pH-modification and NHE1 inhibition on HeLa
cell viability. (a) HeLa cells were incubated in standard Dulbecco’s
modified Eagle’s medium (DMEM) at 2, 10, and 20% CO2, and in the HCO3
-
reducing DMEM at 10% CO2 for 3 days. DMEM pre-incubated at the
appropriate CO2 concentration was changed every 12 h. At 1-day intervals,
the viability of the cells was measured by MTT assay. (b) Effects of NHE1
inhibition in various pH-modified media. HeLa cells were incubated in 2%
CO2, 10% CO2, and HCO3
-modified medium in the absence (control, dark
histogram) or presence (NHE1 inhibitor, white histogram) of 100 mM
cariporide. Data shown are means±s.e.m. (n¼ 9). **Po0.01: difference
from control.
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Effects of pHi Modulation on the Actin-Binding
Properties of eEF1A and the eEF1A-Dependent Cell
Viability
In Dictyostelium, eEF1A proteins not only shuttle aminoacyl-
tRNAs in protein translation, but also bind to F-actin. This
binding is regulated by pHi in vitro and in vivo.
19 When pHi
increases, the EF1A-mediated cross-links between actin
filaments dissociate and EF1A is liberated from actin and
binds to aminoacyl-tRNA for protein synthesis.13,15,19 Owing
to the DNA sequence homology between Dictyostelium EF1A
and human eEF1As (Supplementary 2), we sought to de-
termine whether human eEF1A1 and eEF1A2 bind to actin,
and whether their association is controlled by pH. HeLa cells
were transfected with Myc-tagged eEF1A constructs and the
actin binding of eEF1A was measured in the pH-modified
buffers. As shown in Figure 3, the majority of eEF1A1 and
eEF1A2 proteins were bound to actin in the pH 6 actin-binding
buffer. Both eEF1A1 and eEF1A2 protein levels bound to actin
at pH 7 were lower than those bound at pH 6, and actin
binding was almost non-existent at pH 8. These results show
that human eEF1A1 and eEF1A2 are actin-binding proteins,
which have a reduced actin-binding activity in alkaline pH.
Dictyostelium eEF1A has two actin-binding domains, dom-
ains I and III; domain III is responsible for the majority of
actin-binding activity and the carboxy-terminal 54 residues
of domain III (403–456) are the essential actin-binding
residues. The Dictyostelium eEF1ADC protein, which lacks
the C-terminal 54 amino acids, lost more than 90% of the
actin-binding activity.23 Based on the sequence alignment,
residues 408–462 of human eEF1A1 and 408–463 of human
eEF1A2 make up the corresponding carboxy-terminal 54
residues of Dictyostelium eEF1A (Supplementary 2). There-
fore, we constructed human Myc-eEF1A1DC (D408–462)
and Myc-eEF1A2DC (D408–463) clones and measured their
actin-binding activity. As shown in Figure 4a, both
eEF1A1DC and eEF1A2DC almost completely lost actin-
binding activity, even at a pH of 6. Next, we measured the
effects of the carboxy-terminus deletion on eEF1A-dependent
cell viability. It has been shown that over-expression of eEF1A
is associated with increased cell viability.14 As shown in
Figure 4b, transfection of the full-length wild-type eEF1A1
construct induced an increase in cell viability at every pHi. It
is interesting to note that transfection of the carboxy-term-
inal deleted (DC) eEF1A1 construct further increased cell
viability only at acidic pHi. These results indicate that dis-
sociation from actin is important for eEF1A-dependent cell
viability. At acidic pHi, where most of the eEF1A is bound to
Figure 3 pH-dependent actin binding of human eukaryotic translation
elongation factor 1 a (eEF1As). Constructs expressing Myc-tagged human
eEF1As were transiently transfected into HeLa cells. After 48 h, cells were
lysed in the actin-binding buffer with pH values ranging from 6 to 8, and
the lysates were incubated with actin-biotin. After incubation, immobilized
streptavidin was added to the sample and biotin-binding proteins or lysates
were analyzed by immunoblotting with anti-Myc (Santa Cruz), anti-b-actin
(Santa Cruz), or anti-eEF1A (Upstate) antibodies. The control cells were
mock transfected with pcDNA3.1/Zeo(þ ). Immunoblotting of protein
lysates using anti-eEF1A antibody represents the amounts of both
endogenous and over-expressed eEF1A proteins.
Figure 4 Role of actin binding of eukaryotic translation elongation factor 1
a (eEF1A) in pH-dependent cell viability. HeLa cells were seeded onto a 12-
well plate after the transfection of wild-type (WT) or the carboxy-terminal
actin-binding domain-deleted (DC) eEF1A constructs. (a) Actin-binding
experiments detailed in Figure 3 were carried out with constructs for WT
and DC eEF1As and in actin-binding buffer at pH 6, in which maximal actin
binding is expected. (b) HeLa cells were transfected with constructs for WT
and DC eEF1As and were incubated under each pH-modified condition for
48 h. Cell viability was measured with the MTT assay and the values were
normalized to that of the neutral control for each set of experiments. Data
shown are means±s.e.m. (n¼ 9). *Po0.05: difference from WT-Myc-eEF1A.
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actin, the deletion of the actin-binding domain significantly
increases cell viability, whereas at alkaline pHi, deletion of the
actin-binding domain does not affect cell viability because
most of eEF1A is already dissociated from actin.
eEF1A is Necessary for pHi-Dependent Cell Viability
To investigate the function of endogenous eEF1A in human
cancer cells, we used RNA interference to specifically deplete
eEF1A protein in HeLa cells. To confirm the siRNA-mediated
eEF1A knockdown, cells were harvested 2 days after
transfection with the control scrambled siRNA and eEF1A
isoform-specific siRNAs in each condition, and the protein
samples were blotted with the anti-eEF1A antibody that
detects both eEF1A1 and eEF1A2. As shown in Figure 5a,
treatment with eEF1A1 siRNA alone or eEF1A2 siRNA alone
induced only a small change in the total eEF1A protein level.
However, co-transfection with both eEF1A1 and eEF1A2
siRNAs decreased the amount of total eEF1A proteins by 54%
(alkaline condition)–76% (acidic condition) (Figure 5b). The
eEF1A1 and eEF1A2 siRNA-transfected cells were incubated
in 2, 10, and 20% CO2 incubation chambers for 48 h, and the
respective cell viability was measured. It is interesting to note
that knockdowns of eEF1A greatly decreased cell viability in
alkaline and neutral media, but not in acidic media (Figure
5c). These results suggest that endogenous eEF1A has a key
role in cell viability under alkaline or neutral conditions,
where a considerable amount of eEF1A is in the unbound
free form, but not in the acidic condition where most of
eEF1A is in the actin-bound state.
DISCUSSION
Abnormally high intracellular alkalinization is a well-docu-
mented phenotype in tumor cells, and is thought to play a
pivotal role in neoplastic transformation and maintenance
of neoplastic progression.1,10,24 For example, increased pHi of
tumor cells is associated with increased in vivo tumor growth,
DNA synthesis, and cell-cycle progression.1 In addition, cyto-
plasmic alkalinization is an important signal in controlling the
rate of cell division and activation of DNA and protein synthesis
in fibroblast and Dictyostelium.15,25 In this study, we provide
several lines of evidence that eEF1A plays a direct and pivotal
role in intracellular alkalinization-induced tumor cell growth.
The primary function of eEF1A is to shuttle aminoacyl
t-RNA during protein translation. The two eEF1A isoforms,
eEF1A1 and eEF1A2, appears to have similar activities in
protein elongation. In addition to its major role as a protein
translation factor, eEF1A stimulates a filopodia formation
through cooperation with PI4KIII b and also regulates
re-cycling of M4 muscarinic acetylcholine receptors. These
non-canonical roles of eEF1A based on the strong relation of
eEF1A with actin, and furthermore, eEF1A actually binds to
actin.26–28 It is interesting to note that the binding of eEF1A
to F-actin has pH-dependent kinetics. For example,
Dictyostelium eEF1A showed a Kd value of 0.2 mM at pH 6.5,
and this value increases greatly to a Kd of 42.2 mM at pH
7.8.19 As shown in Figure 3, we also confirmed the pH-de-
pendent actin-binding for human eEF1A1 and eEF1A2. It has
been proposed that a weakened association of eEF1A with
actin may be related to cancer cell growth and metastasis via
an altered organization of the actin cytoskeleton and the
Figure 5 Effects of eukaryotic translation elongation factor 1 a (eEF1A) knockdowns on pH-dependent cell viability. HeLa cells were transfected with
eEF1A1 and eEF1A2 siRNAs and incubated according to each pH-modified condition for 48 h. Control cells were transfected with the scrambled siRNA. (a, b)
Effects of the siRNA-mediated knockdown of endogenous eEF1As were examined using immunoblotting with anti-eEF1A antibody (Upstate). Control
immunoblot was blotted with anti-g-tubulin antibody from Sigma (St Louis, MO, USA). Results of multiple (n¼ 3) experiments are summarized in panel B. (c)
Cell viability was measured with the MTT assay. Data shown are means±s.e.m. (n¼ 4). *Po0.05, **Po0.01: difference from control.
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differential translation of mRNAs.14 In fact, it has been
shown that the binding affinity of eEF1A to F-actin in tumor
cells is lower than that for eEF1A in normal cells.14 The re-
sults in this study indicate that increased pHi of tumor cells is
an important factor for the dissociation of eEF1A from the
actin cytoskeleton. In immunofluoroscence experiments, we
found that eEF1A was highly co-localized with F-actin in
HeLa cells (data not shown), as previously reported.14
Treatment with alkaline conditions seemed to evoke a global
increase of eEF1A fraction in cytosol, which partially in-
creased cytosolic haziness in the immunofluoroscence ima-
ges. However, significant fractions of eEF1A were still bound
to F-actin. It seems that a large pool of eEF1A is intercalated
with and not dissociable from F-actin. For this reason, we
could not observe dramatic changes in the immuno-
fluoroscence experiments, such as complete dissociation of
eEF1A from F-actin in alkaline conditions. However, this
does not weaken the findings of this study. As shown in
Figure 3, a significant fraction of eEF1A exists in the dis-
sociable pool of F-actin (soluble form in cytosol), and its
binding to actin is under dynamic control of intracellular pH.
Recently, several studies have shown that the two isoforms
of eEF1A serve as growth-enhancing genes, where an increase
in the copy number of eEF1A1 and eEF1A2 can play a critical
role in malignant tumor progression.18 eEF1A1, which maps
to 6q14, is amplified in some childhood brain tumors, and
eEF1A1 is over-expressed in pancreas, breast, lung, and colon
tumors.29–31 In prostate carcinoma, the dominant prostate
tumor-inducing gene 1 (PTI-1), with a 97.7% DNA sequence
homology to eEF1A1, was identified by PCR.30 Its expression
occurs in breast, colon, and lung cancer cells, but not in
normal cells, and it can transform rodent fibroblasts. Anti-
sense-mediated blocking of PTI-1 inhibits tumorigenesis and
results in the reversion of tumor cells to a normal cellular
phenotype.32 As it bears a strong sequence similarity to
eEF1A1, eEF1A2 is also involved in cancer. The amplification
of the eEF1A2 gene, which maps to 20q13, occurs in 20–30%
of ovarian cancer cases18 and two-thirds of breast tumors.33
In addition to eEF1As, the increased expression of another
elongation factor, EIF4E, an mRNA cap-binding factor, is
also associated with tumors in the breast, colon, larynx, and
lungs.34–36 In general, increased expression of the elongation
factor is thought to be associated with tumorigenesis by
enhancing the translation of genes promoting cellular
growth.18,37
Low CO2 incubations alkalinized the HeLa human
cervical adenocarcinoma cells and increased cell viability
(Figures 1 and 2). Incubations at 2% CO2 in the standard
44 mM HCO3
containing DMEM increased the pHi of HeLa
cells from 7.19 to 7.57 (Table 1), which is close to the
physiological upper limit value of 7.65 observed in tumor
cells,1 indicating that the CO2 modification is a suitable
system for this study. Moreover, the viable patterns of cells
under the following three different acidic conditions are: (1)
HCO3
 reduction in DMEM with the standard 10% CO2
incubation, (2) standard HCO3
/CO2 DMEM treated with
the NHE1 inhibitor, and (3) high CO2 incubation (20%)
with the standard 44 mM HCO3
containing DMEM, were
very similar (Figures 1 and 2). Accordingly, changes in cell
viability cannot be attributed to CO2 toxicity, O2 deficiency,
or bicarbonate ion concentration, but are due to cytoplasmic
alkalinization or acidosis.
Inhibition of NHE1 by cariporide affected both the cell
growth rate and the intracellular pH of tumor cells (Figures 2
and 4). NHE1 is quiescent at resting pHi and is activated only
upon cytosolic acidification in normal cells, whereas NHE1 is
hyperactivated, even at resting pHi, in transformed and
tumor cells, which results in an alkalinization of pHi and
acidification of pHe.
1,24 Owing to the insufficient and dis-
organized vascularization of tumor vessels and the increased
metabolism of tumor cells, increased NHE1 activity further
acidifies the microenvironment of tumor cells. This has been
shown to increase the metastatic potential of tumor cells by
promoting neoangiogenesis, anchorage-independent growth,
genetic instability, and invasion.1 Moreover, the cellular al-
kalinization of tumor cells induced by hyperactivation of
NHE1 has been shown to be directly related to increased
protein synthesis and tumor cell growth.1,24,38 The
direct regulation of cytoskeletal dynamics and signal acti-
vation by NHE1 as a scaffolding protein, independent of its
ion-transporting activities, has been suggested to be involved
in NHE1-mediated tumor cell growth and metastasis.1
The results in this study suggest that pH-dependent eEF1A
redistribution may play a role in NHE1-mediated tumor
cell growth.
In conclusion, our study provides sufficient evidence that
human eEF1A plays a role in the intracellular alkalinization-
induced tumor cell growth. We showed that eEF1A is dis-
sociated from actin under alkaline conditions and that
eEF1A-mediated cell growth is augmented with an increase in
levels of unbound free-form eEF1A in HeLa cells. Moreover,
results of the eEF1A knockdown experiments revealed that
eEF1A is necessary for alkalinization-induced cell growth.
These results provide new insight into our understanding of
intracellular alkalinization-induced tumor cell growth. A
detailed understanding of the role of eEF1A in tumorigenesis
will facilitate the development of specific modalities to in-
hibit tumor growth.
Supplementary Information accompanies the paper on the Laboratory
Investigation website (http://www.laboratoryinvestigation.org)
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